“Induced Antileukemic Activity after Blast Modulation is Independent from Immune Checkpoint Marker Expression on Patients’ Blasts or T Cells” (2025) Archives of Clinical and Biomedical Research, 9(6), pp. 521–541. Available at: https://fortunejournals.org/ojs/index.php/acbr/article/view/15154 (Accessed: 17 September 2026).